Article Details
Retrieved on: 2021-10-26 08:45:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
SNG001, an inhaled formulation of interferon beta, will advance to Phase 3 clinical testing in the ACTIV-2 Outpatient Monoclonal Antibodies and ...
Article found on: www.technologynetworks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here